Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 20:11:899.
doi: 10.3389/fneur.2020.00899. eCollection 2020.

Acute Hemorrhagic Leukoencephalitis: A Case and Systematic Review of the Literature

Affiliations

Acute Hemorrhagic Leukoencephalitis: A Case and Systematic Review of the Literature

Pascale Grzonka et al. Front Neurol. .

Abstract

Objectives: To present a patient with acute hemorrhagic leukoencephalitis (AHLE) and a systematic review of the literature analyzing diagnostic procedures, treatment, and outcomes of AHLE. Methods: PubMed and Cochrane databases were screened. Papers published since 01/01/2000 describing adult patients are reported according to the PRISMA-guidelines. Results: A 59-year old male with rapidly developing coma and cerebral biopsy changes compatible with AHLE is presented followed by 43 case reports from the literature including males in 67% and a mean age of 38 years. Mortality was 47%. Infectious pathogens were reported in 35%, preexisting autoimmune diseases were identified in 12%. Neuroimaging revealed uni- or bihemispheric lesions in 65% and isolated lesions of the cerebellum, pons, medulla oblongata or the spinal cord without concomitant hemispheric involvement in 16%. Analysis of the cerebrospinal fluid showed an increased protein level in 87%, elevated white blood cells in 65%, and erythrocytes in 39%. Histology (reported in 58%) supported the diagnosis of AHLE in all cases. Glucocorticoids were used most commonly (97%), followed by plasmapheresis (26%), and intravenous immunoglobulins (12%), without a clear temporal relationship between treatment and the patients' clinical course. Conclusions: Although mortality was lower than previously reported, AHLE remains a life-threatening neurologic emergency with high mortality. Diagnosis is challenging as the level of evidence regarding the diagnostic yield of clinical, neuroimaging and laboratory characteristics remains low. Hence, clinicians are urged to heighten their awareness and to prompt cerebral biopsies in the context of rapidly progressive neurologic decline of unknown origin with the concurrence of the compiled characteristics. Future studies need to focus on treatment characteristics and their effects on course and outcome.

Keywords: immunosuppressive therapy; leukoencephalitis; mortality; outcome; parainfectious disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart.
Figure 2
Figure 2
Cerebral MRI presenting the temporal evolution within 3 days (from left to right) and EEG excerpt. First row: axial T2-weighted FLAIR images showing increasing bilateral confluent widespread hyperintensities of the supratentorial white matter predominantly on the left. Second row: axial T2-weighted FLAIR images revealing new hyperintensities of the left cerebellar peduncle. Third row: axial SWI demonstrating subtle and small susceptibility artifacts in the splenium of the corpus callosum. Fourth row: axial pre- and post-contrast T1-weighted MPRAGE showing enhancement of the left parieto-occipital region. FLAIR, Fluid-Attenuated Inversion Recovery; SWI, Susceptibility Weighted Imaging; MPRAGE, Magnetization-Prepared Rapid Acquisition with Gradient Echo.
Figure 3
Figure 3
(A,B) Histologic workup of the biopsy of the left frontal lobe and the cerebral autopsy. (A) Histology of the biopsy of the left frontal lobe showing perivascular infiltrates (arrow) of neutrophils, eosinophils, and macrophages (Hemalaun Eosin [HE] stain). (B) Histology of the cerebral autopsy revealing diffuse generalized inflammation and acute hemorrhages (arrow) (Hemalaun Eosin [HE] stain).

References

    1. Yildiz O, Pul R, Raab P, Hartmann C, Skripuletz T, Stangel M. Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis. J Neuroinflammation. (2015) 12:175 10.1186/s12974-015-0398-1 - DOI - PMC - PubMed
    1. Bonduelle T, Stricker J, Mineo JF, Massri A, Guesdon C, Barroso B, et al. . Weston-Hurst syndrome with acute hemorrhagic cerebellitis. Clin Neurol Neurosurg. (2018) 173:118–9. 10.1016/j.clineuro.2018.08.007 - DOI - PubMed
    1. Duggal N. Acute hemorrhagic leukoencephalitis associated with autoimmune myopathy. J Vasc Interv Neurol. (2014) 7:19–22. - PMC - PubMed
    1. Sureshbabu S, Babu R, Garg A, Peter S, Sobhana C, Mittal GK. Acute hemorrhagic leukoencephalitis unresponsive to aggressive immunosuppression. Clin Exp Neuroimmunol. (2017) 2017:63–6. 10.1111/cen3.12361 - DOI
    1. Klein CJ, Wijdicks EF, Earnest FT. Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease). J Neurol. (2000) 247:977–9. 10.1007/s004150070060 - DOI - PubMed

Publication types

LinkOut - more resources